期刊文献+

雄激素受体基因CAG多态性对男性激素避孕有效性影响的研究 被引量:1

Effect of (CAG)n Polymorphism of Androgen Receptor Gene on Hormonal Male Contraception
下载PDF
导出
摘要 目的:分析应用肌注十一酸睾酮酯(TU)进行激素避孕的男性志愿者中起反应者与不起反应者雄激素受体(AR)基因(CAG)n微卫星多态性,并探讨该多态性对激素避孕效果的影响。方法:29例TU不起反应者和34例起反应者分别作为试验组和对照组,应用PCR和DNA测序技术对两组外周血标本进行CAG重复数测定,分析该微卫星多态性对激素避孕效果的影响。结果:试验组和对照组CAG重复数的均数分别为23.62和22.97,均数比较差异无显著性(P>0.05)。短组CAG(n≤22)在试验组和对照组的分布分别为51.7%、50.0%;长组CAG(n>22)在试验组和对照组分布分别为48.3%、50.0%,长短组分布相同。CAG重复数与精子密度之间未见相关性。在FSH浓度>0.2IU/L组中,CAG重复数>22的受试者达到无精子症的机会是其他受试者的1.5倍。结论:受试者AR基因(CAG)n重复数呈多态性,但不反应组与反应组之间不具有显著性差异,AR基因CAG重复数或其他因素与男性激素避孕效果之间的关系有待进一步探讨。 Objective: To study (CAG) n polymorphism of the androgen receptor (AR) gene in responders and non-responders of male volunteers who received testosterone undecanoate intramuscular injection for contraception and to explore the effect of the polymorphism on hormonal male contraception. Methods: Twenty-nine non-responders and 34 responders were enrolled in this study as a test and a control group respectively. The numbers of CAG sequence repeats were determined by PCR and DNA sequencing, and the effect of (CAG) n polymorphism on hormonal male contraception was analyzed. Results: The means of CAG repeats of the test and the control group were 23.62 and 22.97, with no significant difference in between ( P 〉 0. 05 ). The short CAG repeats ( n ≤ 22) constituted 51.7% in the test group and 50% in the control, while the long ones (n 〉22) accounted for 48.3% and 50%, respectively. The short and the long group had a similar distribution. No association was found between CAG repeats and sperm concentration. With FSH 〉 0. 2 IU/L, the probability of azoospermia in the long CAG repeat group was 1.5 times that of the short one. Conclusion : CAG repeats in the AR gene presented polymorphism in the subjects, with no significant difference between the respenders and non-responders. Further investigation has yet to be performed into the relationship of hormonal male contraception with CAG repeats or other factots. Natl J Androl, 2008, 14(2 ) : 126-130
出处 《中华男科学杂志》 CAS CSCD 2008年第2期126-130,共5页 National Journal of Andrology
基金 世界卫生组织合作课题(A05233)
关键词 激素避孕 雄激素受体基因 CAG重复序列 基因多态性 hormonal male contraception androgen receptor gene (CAG)n sequence repeat genetic polymorphism
  • 相关文献

参考文献13

  • 1World Health Organization Task Force on Methods for the Regulations of Male Fertility. Rates of testosterone-induced suppression to severe oligozoospermia or azoospermia in two multinational clinical studies[J]. Int J Androl,1995,18(3 ) :157-165.
  • 2谷翊群,王兴海,徐铎,彭林,程立法,黄明孔,黄真嘉,张桂元.十一酸睾酮酯注射液避孕有效性的多中心II期临床研究[J].生殖医学杂志,2003,12(2):67-73. 被引量:22
  • 3崔毓桂,童建孙,王兴海.卵泡刺激素介导睾酮诱导的精子发生抑制的差异[J].生殖医学杂志,2003,12(5):307-310. 被引量:2
  • 4Narula A,Gu YQ,O'Donnell L, et al. Variability in storm suppression during testosterone administration to adult monkeys is related to follicle stimulating hormone suppression and not to intratestieular androgens [ J ]. J Clin Endocrinol Metab, 2002, 87 (7) :3399-3406.
  • 5Weinbauer GF, Schlatt S, Walter V, et al. Testosterone-induced inhibition of spermatogenesis is more closely related to suppression of FSH than to testicular androgen levels in the cynomolgus monkey model ( Macaca faseicularis) [ J ]. J Endocrinol, 2001, 168(1 ) :25-38.
  • 6von Eckardstein S, Schmidt A, Kamischke A, et al. CAG repeat length in the androgen receptor gene and gonadotrophin suppression influence the effectiveness of hormonal male contraception [ J ]. Clin Endocrinol (Oxf), 2002, 57 (5) :647-655.
  • 7Sar M, Lubahn DB, French FS, et al. Immunohistochemical localization of the androgen receptor in rat and human tissues [ J ]. Endocrinology, 1990, 127(6):3180-3186.
  • 8李座祥,唐文豪,汪朝晖,王琳,王媛媛,马潞林,马旭.中国特发性无精子症和少精子症患者雄激素受体基因CAG重复多态性研究[J].中华男科学杂志,2005,11(5):335-338. 被引量:8
  • 9王钢,陈光椿,王晓慧,钟纪根,卢建.中国男性雄激素受体基因(CAG)n重复多态性的初步研究[J].中华医学遗传学杂志,2001,18(6):456-458. 被引量:19
  • 10Yu B, Handelsman DJ. Pharmacogenetic polymorphisms of the AR and metabolism and susceptibility to hormone-induced azoospermia [J]. J Clin Endocrinol Metab, 2001, 86(9) :4406-4411.

二级参考文献53

  • 1李明华,郭小斌,方瑞英,章元沛.十一酸睾丸素的药理作用与临床应用[J].新药与临床,1994,13(5):279-281. 被引量:3
  • 2潘阿根,张思仲.中国汉族人强直性肌营养不良基因CTG重复序列多态性的初步研究[J].中华医学遗传学杂志,1996,13(3):138-142. 被引量:10
  • 3Mauss J,Borsch G,Bormacher K,et al.Seminal fluid analyses,serum FSH,LH and testosterone in seven males before,during and after 250 mg testosterone enanthate weekly over 21 weeks[A].In:Patanelli DJ(ed).Hormonal control of male fertility.US DHEW(NIH),Bethesda,1978.93—122.
  • 4World Health Organization Task Force for the Regulation of Male Fertility.Contraceptive efficacy of testosterone—induced azoospermia in normal men[J].Lancet,1990,336(8721):955—959.
  • 5World Health Organization Task Force for the Regulation of Male Fertility.Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermiain normal men[J].Fertil Steril,1996,65(4):821—829.
  • 6Partsch CJ,Weinbauer GF,Fang RY,et al.Injectable testosterone undecanoate has more favorable pharmacokinetics and pharmacodynamics than testosterone enanthate[J].Eur J Endocrinol,1995,132(4):514—519.
  • 7Zhang GY,Gu YQ,Wang XH,et al.A pharmacokinetic study of injectable testosterone undecanoatein hypogonadal men[J].J Androl,1998,19(6):761—768.
  • 8Zhang GY,Gu YQ,Wang XH,et al.A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men[J].J Clin Endoerinol Metab,1999,84(10):3642-3647.
  • 9World Health Organization.WHO laboratory manual for the examination of human semen and sperm-cervi-cal mucus interaction[M].3 rd ed.Cambridge:Cambridge University Press,1992,3-14.
  • 10Zhang GY,Xiao BL,Chen ZW,et al.Dynamic study of serum gonadotrophin and testosterone levels in gossypol—treated men.Long—term follow—up study of 60 cases[J].Int J Androl,1985,8(3):177—185.

共引文献44

同被引文献22

  • 1李座祥,唐文豪,汪朝晖,王琳,王媛媛,马潞林,马旭.中国特发性无精子症和少精子症患者雄激素受体基因CAG重复多态性研究[J].中华男科学杂志,2005,11(5):335-338. 被引量:8
  • 2戴继灿,李江源.PADAM的诊断以及雄激素补充治疗的安全性问题——中国中老年男子健康研究会(CHISAM)专家会议纪要[J].中国男科学杂志,2006,20(12):68-69. 被引量:9
  • 3Guo Z, Benten WP, Krucken J, et al. Nongenomic testosterone calcium signaling. Genotropic actions in androgen receptor-free macrophages. J Biol Chem, 2002, 277 (33) : 29600-29607.
  • 4Wang C, Nieschlag E, Swerdloff R, et al. Investigation, treat- ment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocri- nol, 2008, 159(5) : 507-514.
  • 5Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med, 2010, 363(2) : 123-135.
  • 6Zitzmann M, Nieschlag E. The CAG repeat polymorphism within the androgen receptor gene and maleness. Int J Androl, 2003, 26 ( 2 ) : 76-83.
  • 7Harkonen K, Huhtaniemi I, Makinen J, et al. The polymorphie androgen receptor gene CAG repeat, pituitary-testicular function and andropausal symptoms in ageing men. Int J Androl, 2003, 26(3) : 187-194.
  • 8Buchanan G, Yang M, Cheong A, et al. Structural and function- al consequences of glutamine tract variation in the androgen re- ceptor. Hum Mol Genet, 2004, 13(16) : 1677-1692.
  • 9Palazzolo I, Gliozzi A, Rusmini P, et al. The role of the polyglu- tamine tract in androgen receptor. J Steroid Biochem Mol Biol, 2008, 108(3-5) : 245-253.
  • 10Svartberg J. Epidemiology: Testosterone and the metabolic syn- drome. Int J Impot Res, 2007, 19(2) : 124-125.

引证文献1

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部